These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3334548)

  • 1. Update on cholinergic enhancement therapy for Alzheimer disease.
    Read SL
    Bull Clin Neurosci; 1987; 52():34-7. PubMed ID: 3334548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic trials using tacrine and other cholinesterase inhibitors.
    Gamzu ER; Thal LJ; Davis KL
    Adv Neurol; 1990; 51():241-5. PubMed ID: 2403716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tetrahydroaminoacridine: a promising 'therapy' for Alzheimer's disease?].
    Drukarch B; Stoof JC
    Ned Tijdschr Geneeskd; 1988 Oct; 132(40):1833-5. PubMed ID: 3185771
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of tetrahydroaminoacridine (tacrine) derivatives and physostigmine in convulsions induced by pentylenetetrazol.
    Herink J; Koupilová M; Hrdina V
    Act Nerv Super (Praha); 1989 Dec; 31(4):303-5. PubMed ID: 2638124
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tacrine].
    Dávila C; Viteri C; de Castro P
    Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The target population in phase I clinical trials of cholinergic compounds in Alzheimer disease: the role of the "bridging study".
    Cutler NR; Sramek JJ
    Alzheimer Dis Assoc Disord; 1995; 9(3):139-45. PubMed ID: 8534412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drug interventions in Alzheimer's disease.
    Stern GM
    Curr Opin Neurol Neurosurg; 1992 Feb; 5(1):100-3. PubMed ID: 1623227
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrine in Alzheimer's disease.
    Levy R
    Lancet; 1989 Aug; 2(8658):329. PubMed ID: 2569126
    [No Abstract]   [Full Text] [Related]  

  • 9. Alzheimer's dementia: recent developments in cholinergic pharmacology.
    Moss DE; Rodriguez LA
    Tex Med; 1987 Jan; 83(1):32-4. PubMed ID: 3824230
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating Alzheimer's disease with cholinergic drugs, Part I.
    Terpstra T; Terpstra T
    Nurse Pract; 1998 Nov; 23(11):90, 92, 97 passim. PubMed ID: 9834506
    [No Abstract]   [Full Text] [Related]  

  • 11. Manipulation of the cholinergic system.
    Geroldi C; Bianchetti A; Trabucchi M
    Funct Neurol; 1997; 12(3-4):187-91. PubMed ID: 9218975
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease.
    Crismon ML
    Pharmacotherapy; 1998; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroprotective therapy of Alzheimer's disease?].
    Mielke R
    Dtsch Med Wochenschr; 1996 Nov; 121(48):1515. PubMed ID: 8983909
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholinergic therapies for Alzheimer's disease. Palliative or disease altering?
    Davis RE; Doyle PD; Carroll RT; Emmerling MR; Jaen J
    Arzneimittelforschung; 1995 Mar; 45(3A):425-31. PubMed ID: 7763338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrine. Alzheimer's disease and the cholinergic theory. A critical review and results of a new therapy.
    Boller F; Orgogozo JM
    Neurologia; 1995 May; 10(5):194-9. PubMed ID: 7619536
    [No Abstract]   [Full Text] [Related]  

  • 16. Tacrine in relation to amino acid transmitters in Alzheimer's disease.
    Bowen DM; Steele JE; Lowe SL; Palmer AM
    Adv Neurol; 1990; 51():91-6. PubMed ID: 1967197
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholinergic therapy in dementia.
    Whitehouse PJ
    Acta Neurol Scand Suppl; 1993; 149():42-5. PubMed ID: 8128838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [More accurate diagnosis could identify patients suitable for tacrine therapy].
    Andreasen N; Eriksson S; Karlsson I; Lindahl B; Lund M; Nordberg A; Wimo A; Winblad B; Astrand R
    Lakartidningen; 1996 Mar; 93(13):1200. PubMed ID: 8656831
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of action of cholinesterase inhibitors in Alzheimer's disease.
    Håkansson L
    Acta Neurol Scand Suppl; 1993; 149():7-9. PubMed ID: 7907455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tacrine and "profitability"].
    Nygaard HA
    Tidsskr Nor Laegeforen; 1997 Feb; 117(5):726. PubMed ID: 9102968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.